Zilebesiran
ALN-AGT01-006
Phase 2 small_molecule completed
Quick answer
Zilebesiran for Mild to Moderate Hypertension is a Phase 2 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Mild to Moderate Hypertension
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed